Austria Oncology NGS Market (2025-2031) | Analysis, Forecast, Growth, Share, Companies, Industry, Trends, Outlook, Competitive Landscape, Size & Revenue, Segmentation, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Austria Country Macro Economic Indicators

3.2 Austria Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Austria Oncology NGS Market - Industry Life Cycle

3.4 Austria Oncology NGS Market - Porter's Five Forces

3.5 Austria Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Austria Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Austria Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F

3.8 Austria Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 Austria Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in Austria

4.2.2 Growing adoption of precision medicine in oncology

4.2.3 Technological advancements in next-generation sequencing (NGS) technology

4.3 Market Restraints

4.3.1 High cost associated with NGS testing

4.3.2 Regulatory challenges and reimbursement issues

4.3.3 Limited awareness and access to advanced oncology NGS testing in certain regions of Austria

6.1 Austria Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Austria Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Austria Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Austria Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2 Austria Oncology NGS Market, By Application

6.2.1 Overview and Analysis

6.2.2 Austria Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F

6.2.3 Austria Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F

6.3 Austria Oncology NGS Market, By Service

6.3.1 Overview and Analysis

6.3.2 Austria Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F

6.3.3 Austria Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F

6.4 Austria Oncology NGS Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 Austria Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.4.3 Austria Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.4.4 Austria Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.5 Austria Oncology NGS Market, By End-use

6.5.1 Overview and Analysis

6.5.2 Austria Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F

6.5.3 Austria Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F

6.5.4 Austria Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.5.5 Austria Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F

6.5.6 Austria Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F

7.1 Austria Oncology NGS Market Export to Major Countries

7.2 Austria Oncology NGS Market Imports from Major Countries

8.1 Average turnaround time for NGS testing

8.2 Rate of adoption of NGS testing in oncology clinics

8.3 Number of partnerships between NGS technology providers and oncology centers in Austria

9.1 Austria Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Austria Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Austria Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F

9.4 Austria Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 Austria Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Austria Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Austria Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters